Currently out of the existing stock ratings of Stephen Baxter, 172 are a BUY (53.92%), 121 are a HOLD (37.93%), 26 are a SELL (8.15%).

Stephen Baxter

Work Performance Price Targets & Ratings Chart

Analyst Stephen Baxter, currently employed at WELLS FARGO, carries an average stock price target met ratio of 72.88% that have a potential upside of 19.17% achieved within 197 days.

Stephen Baxter’s has documented 624 price targets and ratings displayed on 20 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on OSCR, Oscar Health at 13-Aug-2026.

Wall Street Analyst Stephen Baxter

Analyst best performing recommendations are on AGL (AGILON HEALTH).
The best stock recommendation documented was for AGL (AGILON HEALTH) at 5/8/2026. The price target of $72 was fulfilled within 5 days with a profit of $17.77 (32.77%) receiving and performance score of 65.54.

Average potential price target upside

HUM Humana MOH Molina Healthcare OSCR Oscar Health AGL agilon health ANTM Anthem CI Cigna Corp CNC Centene Corp CVS CVS Health Corp CYH Community Health Systems HCA HCA Holdings UNH UnitedHealth Group ELV Elevance Health TDOC Teladoc THC Tenet Healthcare UHS Universal Health Services BTSG BrightSpring Health Services, Common Stock CAH Cardinal Health COR Cencora MCK McKesson PNTG Pennant Group

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 17-Nov-2023

$393

$3.95 (1.02%)

$316

Sell Since 15-May-2026

$370

$-19.05 (-4.90%)

$249

Hold Since 17-Jun-2025

$370

$-19.05 (-4.90%)

$350

Hold Since 11-Oct-2024

$407

$17.95 (4.61%)

$344

Buy Since 09-Apr-2025

$471

$81.95 (21.06%)

$269

Show more analysts

Please expand the browser size to see the chart

Which stock is Stephen Baxter is most bullish on?

Potential upside of $112.95 has been obtained for HUM (HUMANA)

Which stock is Stephen Baxter is most reserved on?

Potential downside of -$23.68 has been obtained for HCA (HCA HOLDINGS)

What Year was the first public recommendation made by Stephen Baxter?

On 2021

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?